Hegerle, N, Guiso, N. Epidemiology of whooping cough and typing of Bordetella pertussis
. Future Microbiology
2013; 8: 1391–1403.
Bordetella pertussis: Why is it still circulating?
Journal of Infection
2014; 68: 119–24.
Nitsch-Osucha, A, et al.
Epidemiological and immunological reasons for pertussis vaccination in adolescents and adults. Respiratory Physiology and Neurobiology
2013; 187: 99–103.
Guimarães, LM, Carneiro, ELNC. Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data. BMC Infectious Diseases
2015; 15: 442.
Barkoff, MA, Gröndahl-Yli-Hannuksela, K, He, Q. Seroprevalence studies of pertussis: what have we learned from different immunized populations. FEMS Pathogens and Diseases. Published online: 24 July 2015. doi: 10.1093/femspd/ftv050.
Cherry, JD. Historical perspective on Pertussis and use of vaccines to prevent it: 100 years of pertussis (the cough of 100 days). Microbe
2009; 2: 139–44.
Leite, D, et al.
Serotypes and genetic profiles of Bordetella pertussis strains isolated in the city of São Paulo, 2006–2008. Jornal de Pediatria
2012; 88: 357–360.
Tsang, SW, et al.
Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods. Journal of Clinical Microbiology
2005; 43: 2449–2451.
Advani, A, Donnelly, D, Hallander, H. Reference system for characterisation of Bordetella pertussis pulsed-field gel electrophoresis profiles. Journal of Clinical Microbiology
2004; 42: 2890–2897.
Lavine, J, et al.
Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine
2010; 29: 11–16.
Ellomaa, A, et al.
Strains variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. Journal of Clinical Microbiology
2005; 43: 3681–3687.
Gent, M, et al.
Analysis of Bordetella pertussis clinical isolates circulating in Eruopean countries during the period 1998–2012. European Journal of Clinical Microbiology and Infectious Diseases
2015; 34: 821–830.
Simmonds, K, et al.
Dominance of two genotypes of Bordetella pertussis during a period of increased pertussis activity in Alberta, Canada: January to August 2012. International Journal of Infectious Diseases
2014; 29: 223–225.
Akamatsu, MA, et al.
Whole-genome sequence of a Bordetella pertussis Brazilian vaccine strain. Genome Announcements
2015; 3: e01570–14.
Bouchez, V, Guiso, N.
Bordetella pertussis, Bordetella parapertussis, vaccines and cycles of whooping cough. FEMS Pathogens and Diseases. Published online: 4 August 2015. doi: 10.1093/femspd/ftv057.
Cassiday, PK, et al.
Changes in predominance of pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates, United States, 2000–2012. Emerging Infectious Diseases
2016; 22: 442–448.
Bottero, D, et al.
Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. Journal of Applied Microbiology
2012; 112: 1266–1276.
Van Loo, IH, Mooi, FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccine. Microbiology
2002; 148: 2011–2018.
Weber, C, et al.
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more 30 years. Journal of Clinical Microbiology
2001; 39: 4396–4403.
Hardwick, TH, et al.
Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis. Journal of Clinical Microbiology
2002; 40: 811–816.